Clinical parameters | No admissions (n = 61) | Admissions (n = 396) | RW p-value |
---|---|---|---|
Age | 52.75 (47.5, 64.56) | 56.06 (48.67, 65.3) | 0.882 |
Female | 40 (65.6%) | 214 (54%) | 0.882 |
Remote / very remote | 59 (96.7%) | 364 (91.9%) | 0.941 |
BMI (kg/m2) (n = 17 & 152) | 26.53 (20.2, 31.6) | 22.95 (18.97, 26.25) | 0.588 |
Never smoker (n = 16 & 134) | 2 (12.5%) | 20 (14.9%) | 1.000 |
Former smoker (n = 16 & 134) | 8 (50%) | 56 (41.8%) | 1.000 |
Current Smoker (n = 16 & 134) | 6 (37.5%) | 58 (43.3%) | 1.000 |
FVC (% predicted) (n = 17 & 152) | 63 (56, 67) | 49 (38.5, 63) | 0.118 |
FEV1 (% predicted) (n = 17 & 152) | 55 (51, 63) | 35.95 (27, 48.5) | 0.029 |
FEV1/FVC (n = 17 & 152) | 0.77 (0.65, 0.82) | 0.65 (0.48, 0.76) | 0.235 |
Respiratory co-morbidities | |||
COPD | 29 (47.5%) | 349 (88.1%) | 0.029 |
Asthma | 11 (18%) | 106 (26.8%) | 0.912 |
Lung cancer | 3 (4.9%) | 15 (3.8%) | 1.000 |
ILD | 0 (0%) | 3 (0.8%) | - |
Other medical co-morbidities | |||
Hypertension | 37 (60.7%) | 250 (63.1%) | 1.000 |
Type 2 diabetes | 28 (45.9%) | 194 (49%) | 1.000 |
Chronic kidney disease | 27 (44.3%) | 157 (39.6%) | 1.000 |
CAD | 17 (27.9%) | 142 (35.9%) | 0.971 |
HF | 4 (6.6%) | 35 (8.8%) | 1.000 |
Bronchiectasis chest CT location | |||
LLL | 43 (70.5%) | 293 (74%) | 1.000 |
RLL | 35 (57.4%) | 249 (62.9%) | 1.000 |
RML | 30 (49.2%) | 164 (41.4%) | 0.971 |
RUL | 18 (29.5%) | 108 (27.3%) | 1.000 |
Lingula | 18 (29.5%) | 110 (27.8%) | 1.000 |
LUL | 11 (18%) | 89 (22.5%) | 1.000 |
Bilateral | 39 (63.9%) | 257 (64.9%) | 1.000 |
Medications | |||
SABA | 28 (45.9%) | 256 (64.6%) | 0.118 |
SAMA | 0 (0%) | 32 (8.1%) | - |
LABA | 21 (34.4%) | 256 (64.6%) | 0.029 |
LAMA | 14 (23%) | 197 (49.7%) | 0.059 |
ICS | 18 (29.5%) | 232 (58.6%) | 0.029 |